Participating Institutions
Participating Institutions
Phase II
BMMRC & UTT
Immunologic Markers of Persons at Highest Risk of Progression of Latent TB Infection to TB
Cohort B
Bhagawan Mahavir Medical Research Centre (BMMRC)
Hyderabad, India
University of Texas Health Science Center, Tyler (UTT)
TX, USA
BJGMC, NIRT, JHU
Host and Microbial Factors Associated with Poor Treatment Response and Progression to Active TB (C-TRIUMPH)
Cohort A (Adult Pulmonary TB, Pediatric TB, and Extrapulmonary TB) and Cohort B
Byramjee Jeejeebhoy Government Medical College (BJGMC)
BJGMC-JHU CRS
Pune, India
National Institute for Research in Tuberculosis (NIRT)
Chennai, India
Johns Hopkins University (JHU)
Baltimore, Maryland
CMC, PGI, UCSF
Host Determinants in the Eicosanoid Pathway that Modulate the Inflammatory Response, Disease Outcome, and Treatment Responsiveness in TB
Cohort A (Adult Pulmonary TB and TB Meningitis)
Christian Medical College (CMC)
Vellore, India
Postgraduate Institute of Medical Education and Research (PGI)
chandigarh, India
University of California San Francisco
san francisco, usa
Hinduja & JHU
MDR-TB Treatment Outcomes, Adverse Effects, Mtb Genotyping, and Pharmacokinetic Testing
Cohort A (Adult / Adolescent MDR-TB) and Cohort B
PD Hinduja National Hospital and Medical Research Centre
Mumbai, India
Johns Hopkins University (JHU)
Baltimore, MD, USA
JIPMER, BU / BMC, RUTGERS, NEIGRIHMS
Biomarkers for Risk of TB and for TB Treatment Failure and Relapse
Cohort A (Adult Pulmonary TB and Pediatric TB) and Cohort B
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
Puducherry, India
Boston University (BU), Boston Medical College (BMC)
Boston, MA, USA
Rutgers University
Newark, NJ, USA
North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIMHS)
shillong, india
MVDRC, NIRT-ICER, UMass
Effects of Diabetes and Prediabetes on TB Severity
Cohort A (Adult Pulmonary TB)